Literature DB >> 22859499

Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review.

Sean Yaphe1, Nikki Bozinoff, Rachel Kyle, Sushmita Shivkumar, Nitika Pant Pai, Marina Klein.   

Abstract

BACKGROUND: A recent increase in reports of acute hepatitis C virus infection (HCV) in HIV-infected and HIV-uninfected men who have sex with men (MSM), with the sole risk factor being sexual exposure, has led to routine screening and targeted prevention requests for this population; current evidence for this necessity is unclear.
OBJECTIVE: A systematic review was conducted to assess the incidence of HCV infection among studies conducted in HIV-positive and/or HIV-negative MSM to explore the implications for routine HCV screening. DATA SOURCES: The MEDLINE, EMBASE and BIOSYS databases were searched for the period January 2000 to May 2012, yielding 21 studies. Six conferences were hand-searched for the same period yielding four abstracts. STUDY SELECTION: Only studies in English presenting incidence rates of HCV and specifying HIV status were included. DATA ABSTRACTION: Data were abstracted by two authors using predefined data fields. The STROBE checklist was used to assess study quality. DATA SYNTHESIS: Data were divided into HIV-negative MSM and HIV-positive MSM subgroups, and HCV incidence density measurements were pooled. Using a DerSimonian-Laird random effects model, pooled incidence was 1.48/1000 person-years (95% CI 0.75 to 2.21) for the HIV-negative MSM subgroup. The HIV-positive MSM subgroup was at 4.1 times higher risk of acquiring HCV at 6.08/1000 person-years (95% CI 5.18 to 6.99). Studies directly comparing subgroups estimated a pooled risk difference of 3.45/1000 person-years (95% CI 1.63 to 5.27).
CONCLUSION: HIV-positive MSM were at higher risk for acute HCV infection than HIV-negative MSM, substantiating the need for routine screening initiatives. Insufficient evidence exists to warrant routine screening of HIV-negative MSM, except on a case-by-case basis, such as high-risk sexual behaviour.

Entities:  

Mesh:

Year:  2012        PMID: 22859499     DOI: 10.1136/sextrans-2012-050566

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  56 in total

Review 1.  Updating the management of sexually transmitted infections.

Authors:  Catriona Ooi; David Lewis
Journal:  Aust Prescr       Date:  2015-12-01

2.  Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis.

Authors:  Kimberly J Alvarez; Arlene Smaldone; Elaine L Larson
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.725

3.  Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.

Authors:  Christoph Boesecke; Patrick Ingiliz; Thomas Reiberger; Hans-Jürgen Stellbrink; Sanjay Bhagani; Emma Page; Stefan Mauss; Thomas Lutz; Esther Voigt; Marguerite Guiguet; Marc-Antoine Valantin; Axel Baumgarten; Mark Nelson; Martin Vogel; Jürgen K Rockstroh
Journal:  Infection       Date:  2016-02       Impact factor: 3.553

4.  [Not Available].

Authors:  Mark Hull; Pierre Giguère; Marina Klein; Stephen Shafran; Alice Tseng; Pierre Côté; Marc Poliquin; Curtis Cooper
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

Review 5.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

6.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

7.  Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.

Authors:  Moisés Uriarte-Pinto; Herminia Navarro-Aznarez; Natalia De La Llama-Celis; Piedad Arazo-Garcés; Ana María Martínez-Sapiña; María Reyes Abad-Sazatornil
Journal:  Int J Clin Pharm       Date:  2018-03-20

Review 8.  HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.

Authors:  Marianne Martinello; Behzad Hajarizadeh; Jason Grebely; Gregory J Dore; Gail V Matthews
Journal:  Curr HIV/AIDS Rep       Date:  2017-06       Impact factor: 5.071

9.  Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment.

Authors:  Bevin Hearn; David Delbello; Joseph Lawler; Michel Ng; Alyson Harty; Douglas T Dieterich
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-11

Review 10.  The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease.

Authors:  John W Ward
Journal:  Top Antivir Med       Date:  2013 Feb-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.